Prism Johnson (500338) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
21 Aug, 2026Executive summary
Q1 FY25 consolidated revenue (ex-RQBE) declined 8.7% year-over-year to ₹1,666 crore, while consolidated revenue from operations was ₹1,763.15 crore, down from ₹1,942.15 crore in Q1 FY24.
EBITDA grew 5.3% year-over-year to ₹155 crore, with margin expanding by 130 bps to 9.3%.
Net loss after tax and non-controlling interest stood at ₹7.70 crore for Q1 FY25, compared to a profit of ₹17.89 crore in Q1 FY24.
Free cash flow (pre-capex and investments) was ₹76 crore in Q1 FY25.
Financial highlights
Prism Cement revenue declined 15.1% YoY to ₹773 crore; HRJ revenue down 1.7% YoY to ₹539 crore; Prism RMC revenue down 3.5% YoY to ₹353 crore.
EBITDA margin improved to 9.3% from 8.0% YoY, while consolidated EBITDA margin (Operating Margin) for Q1 FY25 was 7.57%.
Net debt to TTM EBITDA at 1.6x; net debt/equity at 0.5x as of June 30, 2024.
Annualized ROCE declined 30 bps YoY to 10.7%; capital employed decreased 12.5% YoY to ₹2,206 crore.
EPS for Q1 FY25 was ₹-0.15, compared to ₹0.36 in Q1 FY24.
Outlook and guidance
Management targets to achieve past peak performance in the medium term, focusing on cost competitiveness, premium product mix, and capacity utilization.
Strong medium-term demand outlook for cement and RMC, driven by housing and infrastructure sectors.
No explicit forward-looking guidance provided, but management commentary and segment results indicate continued focus on cost control and operational efficiency.
Latest events from Prism Johnson
- FY25 revenue reached ₹7,310 crore with strong cash flow and focus on sustainability and innovation.500338
Corporate presentation - Q2 FY25 saw a sharp YoY decline in revenue and margins, resulting in a significant net loss.500338
Q2 25/25 - Q3 FY25 revenue and net profit improved, but EBITDA and margins declined sharply.500338
Q3 24/25 - FY25 profit dropped on margin pressures and exceptional items, with debt reduction and asset sale.500338
Q4 24/25 - Revenue grew year-over-year, but profit declined amid margin pressures and arbitration.500338
Q1 25/26 - Quarterly profit returned with higher margins, led by cement and HRJ segment growth.500338
Q2 25/26 - Profitability and margins rose sharply, aided by asset sales despite labor code expenses.500338
Q3 25/26 - Revenue and EBITDA rose, but net profit was hit by exceptional items and insurance sale pending.500338
Q4 25/26 - Record EBITDA growth and profit surge driven by asset sales and insurance divestment.500338
Q1 26/27